Lactoferrin, a bird’s eye view

Hans J. Vogel

doi:10.1139/o2012-016

journal article Jun 01, 2012

Lactoferrin, a bird’s eye view

Hans J. Vogel

Biochemistry and Cell Biology Vol. 90 No. 3 pp. 233-244 · Canadian Science Publishing

View at Publisher Save 10.1139/o2012-016

Abstract

Lactoferrin is an abundant iron-binding protein in milk. This 80 kDa bilobal glycoprotein is also present in several other secreted bodily fluids, as well as in the secondary granules of neutrophils. The potent iron-binding properties of lactoferrin can locally create iron deficiency, and this is an important factor in host defense as it prevents bacteria from growing and forming biofilms. In addition to having antibacterial activity, lactoferrin is now known to have a long list of other beneficial biological properties. It has direct antiviral, antifungal, and even some anticancer activities. It can also promote wound healing and bone growth, or it can act as an iron carrier. Moreover, lactoferrin displays a cytokine-like “alarmin” activity, and it activates the immune system. Simultaneously, it can bind endotoxin (lipopolysaccharide), and in doing so, it modulates the activity of the host immune response. The majority of these intriguing biological activities reside in the unique positively charged N-terminal region of the protein. Interestingly, several peptides, which retain many of the beneficial activities, can be released from this region of lactoferrin. An isoform of the human protein, known as delta-lactoferrin, is expressed inside many cells, where it acts as a transcription factor. Lactoferrin purified from human and bovine milk have very similar but not completely identical properties. Lactoferrin receptors have been identified on the surface of various cells, and some of these can bind both the human and the bovine protein. Because of the extensive health-promoting effects of lactoferrin, there has been considerable interest in the use of bovine or human lactoferrin as a “protein nutraceutical” or as a therapeutic protein. When lactoferrin is used as a “biologic drug”, it seems to be orally active in contrast to most other therapeutic proteins.

Topics

No keywords indexed for this article. Browse by subject →

References

122

[1]

10.1146/annurev-immunol-020711-074942

[2]

10.1073/pnas.84.7.1769

[3]

10.1042/bj20041270

[4]

Appelmelk B.J. Infect. Immun. (1994) 10.1128/iai.62.6.2628-2632.1994

[5]

10.1126/science.327545

[6]

Artym J. Postepy Hig. Med. Dosw. (Online) (2007)

[7]

10.1167/iovs.10-6352

[8]

10.1021/bi00415a061

[9]

10.1023/b:biom.0000027694.40260.70

[10]

10.1139/o11-071

[11]

10.1007/s10534-010-9299-z

[12]

10.1016/0167-4838(92)90346-f

[13]

10.1007/s11894-010-0145-9

[14]

10.1023/b:biom.0000027707.82911.be

[15]

10.3390/molecules16086992

[16]

Beutler B. J. Endotoxin Res. (2002)

[17]

10.1007/978-3-540-75203-5_1

[18]

10.1007/s00198-009-0839-8

[19]

10.1007/s00011-010-0211-7

[20]

10.1152/ajpendo.90938.2008

[21]

10.1139/o11-085

[22]

10.1016/j.it.2007.06.002

[23]

10.1038/nrmicro1710

[24]

10.1016/j.peptides.2011.07.017

[25]

10.1007/s005990050059

[26]

10.1038/nsmb.2251

[27]

Structure of the Human Transferrin Receptor-Transferrin Complex

Yifan Cheng, Olga Zak, Philip Aisen et al.

Cell 10.1016/s0092-8674(04)00130-8

[28]

10.1007/s10534-010-9361-x

[29]

10.1038/nm1565

[30]

10.1210/en.2003-1307

[31]

Crichton, R.R. 2009. Iron Metabolism: From Molecular Mechanisms to Clinical Consequences. John Wiley & Sons Ltd., Chichester, West Sussex. 10.1002/9780470010303

[32]

Dave M. Gastroenterol. Hepatol. (N.Y.) (2012)

[33]

Davidson L.A. Am. J. Physiol. (1988)

[34]

de la Rosa G. J. Immunol. (2008) 10.4049/jimmunol.180.10.6868

[35]

10.1007/s00018-005-5109-0

[36]

10.1097/jto.0b013e3182156250

[37]

10.1128/aac.48.12.4919-4921.2004

[38]

10.1074/jbc.m109.036426

[39]

10.1016/s0304-4165(01)00222-7

[40]

Elass-Rochard E. Biochem. J. (1995) 10.1042/bj3120839

[41]

10.1002/ijc.21886

[42]

10.1016/j.jss.2007.12.754

[43]

10.1016/j.bbamcr.2012.01.014

[44]

10.1016/j.bbagen.2011.08.004

[45]

10.2741/212

[46]

10.1007/s00018-005-5373-z

[47]

10.1111/j.1600-0765.2012.01479.x

[48]

10.1021/ja01498a029

[49]

10.1007/s11894-010-0146-8

[50]

10.1016/j.bbamem.2007.04.018

Showing 50 of 122 references

Cited By

218

Effects of Curcumin and Lactoferrin to Inhibit the Growth and Migration of Prostatic Cancer Cells

Erica Costantini, Marta Di Nicola · 2022

International Journal of Environmen...

The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria

Douglas B. Kell, Eugene L. Heyden · 2020

Frontiers in Immunology

Human calprotectin affects the redox speciation of iron

Toshiki G. Nakashige, Elizabeth M. Nolan · 2017

Metallomics

Lactoferrin in a Context of Inflammation-Induced Pathology

Marian L. Kruzel, Michal Zimecki · 2017

Frontiers in Immunology

Benefits of Lactoferrin, Osteopontin and Milk Fat Globule Membranes for Infants

Hans Demmelmair, Christine Prell · 2017

Nutrients

Metrics

218

Citations

122

References

Details

Published: Jun 01, 2012
Vol/Issue: 90(3)
Pages: 233-244
License: View

Authors

H

Hans J. Vogel

Biochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, AB T2N 1N4, Canada.

Cite This Article

Hans J. Vogel (2012). Lactoferrin, a bird’s eye view. Biochemistry and Cell Biology, 90(3), 233-244. https://doi.org/10.1139/o2012-016

Lactoferrin, a bird’s eye view

You May Also Like